ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
1,619
113
0
Cost of Revenue
-
0
1,619
113
0
Gross Profit
-
0
0
0
0
Operating Expenses
Research Development
215,956
239,108
252,902
132,760
69,611
Selling General and Administrative
90,141
47,474
38,102
26,148
16,718
Total Operating Expenses
306,097
286,582
291,004
157,858
86,329
Operating Income or Loss
-306,097
-286,582
-291,004
-157,858
-86,329
Interest Expense
19,459
17,185
-
-
-
Total Other Income/Expenses Net
-989
-9,847
2,125
1,604
859
Income Before Tax
-317,354
-296,429
-288,879
-156,254
-85,470
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-317,354
-296,429
-288,879
-156,254
-85,470
Net Income
-317,354
-296,429
-288,879
-156,254
-85,470
Net Income available to common shareholders
-322,805
-331,934
-288,879
-156,254
-85,470
Reported EPS
Basic
-
-4.87
-4.95
-3.23
-2.11
Diluted
-
-4.87
-4.95
-3.23
-2.11
Weighted average shares outstanding
Basic
-
68,099
58,347
48,408
40,587
Diluted
-
68,099
58,347
48,408
40,587
EBITDA
-
-286,582
-291,004
-157,858
-86,329